BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 29449149)

  • 1. Manufacturing Exosomes: A Promising Therapeutic Platform.
    Colao IL; Corteling R; Bracewell D; Wall I
    Trends Mol Med; 2018 Mar; 24(3):242-256. PubMed ID: 29449149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes for repair, regeneration and rejuvenation.
    Basu J; Ludlow JW
    Expert Opin Biol Ther; 2016; 16(4):489-506. PubMed ID: 26817494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manufacturing Therapeutic Exosomes: from Bench to Industry.
    Ahn SH; Ryu SW; Choi H; You S; Park J; Choi C
    Mol Cells; 2022 May; 45(5):284-290. PubMed ID: 35534190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between molecular content of mesenchymal stem cells derived exosomes and their potentials: Opening the way for exosomes based therapeutics.
    Jafari D; Malih S; Eslami SS; Jafari R; Darzi L; Tarighi P; Samadikuchaksaraei A
    Biochimie; 2019 Oct; 165():76-89. PubMed ID: 31302163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular vesicles, exosomes and shedding vesicles in regenerative medicine - a new paradigm for tissue repair.
    Bjørge IM; Kim SY; Mano JF; Kalionis B; Chrzanowski W
    Biomater Sci; 2017 Dec; 6(1):60-78. PubMed ID: 29184934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome manufacturing status.
    Whitford W; Guterstam P
    Future Med Chem; 2019 May; 11(10):1225-1236. PubMed ID: 31280675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome and Biomimetic Nanoparticle Therapies for Cardiac Regenerative Medicine.
    Stine SJ; Popowski KD; Su T; Cheng K
    Curr Stem Cell Res Ther; 2020; 15(8):674-684. PubMed ID: 32148200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post isolation modification of exosomes for nanomedicine applications.
    Hood JL
    Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome Processing and Characterization Approaches for Research and Technology Development.
    Lai JJ; Chau ZL; Chen SY; Hill JJ; Korpany KV; Liang NW; Lin LH; Lin YH; Liu JK; Liu YC; Lunde R; Shen WT
    Adv Sci (Weinh); 2022 May; 9(15):e2103222. PubMed ID: 35332686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using exosomes, naturally-equipped nanocarriers, for drug delivery.
    Batrakova EV; Kim MS
    J Control Release; 2015 Dec; 219():396-405. PubMed ID: 26241750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes isolation protocols: facts and artifacts for cardiac regeneration.
    Angelini F; Ionta V; Rossi F; Pagano F; Chimenti I; Messina E; Giacomello A
    Front Biosci (Schol Ed); 2016 Jun; 8(2):303-11. PubMed ID: 27100708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manufacturing road map for tissue engineering and regenerative medicine technologies.
    Hunsberger J; Harrysson O; Shirwaiker R; Starly B; Wysk R; Cohen P; Allickson J; Yoo J; Atala A
    Stem Cells Transl Med; 2015 Feb; 4(2):130-5. PubMed ID: 25575525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removing the stumbling block of exosome applications in clinical and translational medicine: expand production and improve accuracy.
    Han L; Zhao Z; He C; Li J; Li X; Lu M
    Stem Cell Res Ther; 2023 Apr; 14(1):57. PubMed ID: 37005658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis.
    Wang J; Li W; Lu Z; Zhang L; Hu Y; Li Q; Du W; Feng X; Jia H; Liu BF
    Nanoscale; 2017 Oct; 9(40):15598-15605. PubMed ID: 28990632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome analysis: a promising biomarker system with special attention to saliva.
    Zheng X; Chen F; Zhang J; Zhang Q; Lin J
    J Membr Biol; 2014 Nov; 247(11):1129-36. PubMed ID: 25135166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic application of mesenchymal stem cell-derived exosomes: A promising cell-free therapeutic strategy in regenerative medicine.
    Motavaf M; Pakravan K; Babashah S; Malekvandfard F; Masoumi M; Sadeghizadeh M
    Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):74-9. PubMed ID: 27453276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensor technologies for quality control in engineered tissue manufacturing.
    McCorry MC; Reardon KF; Black M; Williams C; Babakhanova G; Halpern JM; Sarkar S; Swami NS; Mirica KA; Boermeester S; Underhill A
    Biofabrication; 2022 Oct; 15(1):. PubMed ID: 36150372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic points to consider regarding the preparation of extracellular vesicles and their clinical applications in Japan.
    Tsuchiya A; Terai S; Horiguchi I; Homma Y; Saito A; Nakamura N; Sato Y; Ochiya T; Kino-Oka M;
    Regen Ther; 2022 Dec; 21():19-24. PubMed ID: 35619946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
    Zarovni N; Corrado A; Guazzi P; Zocco D; Lari E; Radano G; Muhhina J; Fondelli C; Gavrilova J; Chiesi A
    Methods; 2015 Oct; 87():46-58. PubMed ID: 26044649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated systems for exosome investigation.
    Peterson MF; Otoc N; Sethi JK; Gupta A; Antes TJ
    Methods; 2015 Oct; 87():31-45. PubMed ID: 25916618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.